{"result": "(\"entity\"<|>BONE MARROW TRANSPLANT<|>EVENT<|>Bone marrow transplant is a medical procedure that involves the transplantation of blood-forming stem cells to treat various conditions, including cancers and blood disorders.)\n##\n(\"entity\"<|>PARENTERAL NUTRITION<|>EVENT<|>Parenteral nutrition is a method of feeding that bypasses the gastrointestinal tract, providing nutrients directly into the bloodstream, often used for patients unable to eat by mouth.)\n##\n(\"entity\"<|>CLINICAL TRIAL<|>EVENT<|>A clinical trial is a research study conducted with human participants to evaluate the effects and efficacy of medical interventions, such as drugs or procedures.)\n##\n(\"entity\"<|>NUTRITION<|>ORGANIZATION<|>Nutrition is a field of study and practice focused on the dietary needs of individuals, particularly in medical contexts such as cancer treatment and recovery.)\n##\n(\"entity\"<|>G. VAN DEN BERGHE<|>PERSON<|>G. Van den Berghe is a researcher known for studies on intensive insulin therapy and its effects on critically ill patients.)\n##\n(\"entity\"<|>S. WEISDFORD<|>PERSON<|>S. Weisdorf is a researcher involved in studies related to bone marrow transplantation and nutritional support for patients.)\n##\n(\"relationship\"<|>BONE MARROW TRANSPLANT<|>PARENTERAL NUTRITION<|>Parenteral nutrition is often used to support patients undergoing bone marrow transplants, providing essential nutrients during recovery<|>8)\n##\n(\"relationship\"<|>CLINICAL TRIAL<|>BONE MARROW TRANSPLANT<|>Clinical trials are conducted to evaluate the effectiveness of treatments, including those for bone marrow transplant patients<|>7)\n##\n(\"relationship\"<|>G. VAN DEN BERGHE<|>CLINICAL TRIAL<|>G. Van den Berghe has conducted clinical trials related to intensive insulin therapy in critically ill patients, which may include those undergoing bone marrow transplants<|>6)\n##\n(\"relationship\"<|>S. WEISDFORD<|>BONE MARROW TRANSPLANT<|>S. Weisdorf has researched nutritional support in the context of bone marrow transplantation<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 2.                        43.   Lough M, Watkins R, Campbell M, Carr K, Burnett\n31.  Sefcick A, Anderton D, Byrne JL, Teahon K, Russell                           A, Shenkin A. Parenteral nutrition in bone marrow\n     NH. Naso-jejunal feeding in allogenic bone ma-                               transplantation. Clin Nutr 1990; 9(2): 97-101.\n     rrow transplant recipients: results of a pilot study.                  44.   Roberts S, Miller J, Pineiro L, Jennings L. Total pa-\n     Bone Marrow Transplant. 2001; 28 (12): 1135-                                 renteral nutrition vs oral diet in autologous hema-\n     1139.                                                                        topoietic cell transplant recipients. Bone Marrow\n32.  Szluga DJ, Stuart RK, Brookmeyer R, Utermohlen                               Transplant 2003; 32: 715-721.\n     V, Santos GW. Nutritional support of bone ma-                          45.   Weisdorf S, Hofland C, Sharp HL. Total parenteral\n     rrow transplant recipients: a prospective, rando-                            nutrition in bone marrow transplantation: a clini-\n     mized clinical trial comparing total parenteral nu-                          cal evaluation. J Pediatr Gastroenteral Nutr 1984;\n     trition to an enteral feeding program. Cancer Res                            3:95-100.\n     1987; 47:3309-3316.                                                    46.   Weisdorf S, Lysne J, Wind D, Haake RJ, Sharp HL,\n33.  Hopman GD, Pena EG, Le Cessie S, Van Weel MH,                                Goldman A, Schissel K, McGlave PB, Ramsay NK,\n     Vossen JM, Mearin ML. Tube feeding and bone                                  Kersey JH. Positive effect of prophylactic total pa-\n     marrow       transplantation.       Med     Pediatr     Oncol.               renteral nutrition on long-term outcome of bone\n     2003; 40 (6): 375-379.                                                       marrow      transplantation.      Transplantation       1987;\n34.  Seguy D, Berthon C, Micol JB, Darré S, Dalle JH,                             43:833-838.\n     Neuville S, Bauters F, Jouet JP, Yakoub-Agha I. Ente-                  47.   Cetin T, Arpaci F, Dere F, Turan M, Orturk B, Ko-\n     ral feeding and early outcomes of patients under-                            murcus S, Ozet A, Beyzadeoglu M, Kaptan K, Be-\n     going allogenic stem cell transplantation following                          yan C, Yalcin A. Total parenteral nutrition delays\n     myeloablative conditioning. Transplantation 2006;                            platelet engraftment in patients who undergo au-\n     82: 835-839.                                                                 tologous hematopoietic stem cell transplantation.\n35.  Cope Fo. Prophylactic enteral support to BMT pa-                             Nutrition 2002; 18:599-603.\n     tients reduces length of hospital stay, improves GI                    48.   Mousavi M, Hayatshahi A, Sarayani A, Hadjibabaie\n     integrity and nutritional status, and reduces intake                         M, Javadi M, Torkamandi H, et al. Impact of clini-\n\n---\n\n672      BLOQUE: NUTRICIÓN EN ONCOLOGÍA\n\ncal pharmacist-based parenteral nutrition service for bone marrow transplantation patients: a randomized clinical trial. Support Care Cancer 2013; 21:3441e8.\n\n49. Tavakoli-Ardakani M, Neman B, Mehdizadeh M, Hajifathali A, Salamzadeh J, Tabarraee M. Clinical effect of individualized parenteral nutrition vs conventional method in patients undergoing autologous hematopoietic SCT. Bone Marrow Transpl 2013; 48:958e62.\n\n50. Reed MD, Halpin TC, Herzing RH, Gross S. Cyclic parenteral nutrition during allogenic bone marrow transplantation. J Parenter Enteral Nutr 1981; 5 (1):37-39.\n\n51. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F y cols. Intensive insulin control in critically ill patients. New Engl J Med 2001; 345 (19):1359-1367.\n\n52. Berkers J, Gunst J, Vanhorebeek I, Van den Berghe G. Glycaemic control and perioperative organ protection. Best Pract Res Clin Anaesthesiol 2008; 22(1):135-149.\n\n53. Van den Berghe G, Wilmer A, Herman G, Meersseman W, Wouters P, Milanti G, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive Insulin Therapy in the Medical ICU. N Engl J Med 2006; 354 (5): 449-461.\n\n54. Wiener RS, Wiener DC, Larson RJ . Benefits and risks of tight glucose control in critically ill adults: A meta-analysis. JAMA 2008; 300:933-944.\n\n55. Derr RL, Hsiao VC, Saudek CD. Anteced\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}